Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy
<i>Background and Objectives</i>: Thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) is used to treat acute ischemic stroke. Dabigatran is a reversible thrombin inhibitor approved for stroke prevention in patients with nonvalvular atrial fibrillation. In such cases, thro...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2022-09-01
|
| Collection: | Medicina |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/1648-9144/58/10/1355 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|